Polio or infantile paralysis is caused by poliovirus that is transmitted by contact with feces (unwashed hands) or contaminated water. Many people get this infection without even knowing it. In about 1% of those infected, the disease causes painful and often irreversible paralysis. These paralyzes affect the arms and/or legs. Before the Vaccine Poliomyelitis appeared, it was common to put a healthy child to bed at night and find him paralyzed for life the next day. This vaccine contains killed viruses from all 3 strains of the poliovirus. Its action is supported by an aluminum salt. Polio vaccination requires a minimum of 3 doses (adults), and a total of 5 doses when started in infants. Boosters are only needed for people at risk of exposure in countries where polio persists.
How does Vaccine Poliomyelitis Work?
The growth of effective Vaccine Poliomyelitis to stop paralytic polio happened to be one of the most important medical advances of the twentieth century. The inactivated vaccine against polio (IPV or Salk vaccine), was licensed in 1955; the live attenuated oral vaccine (OPV or Sabin) was licensed as monovalent in 1961 and as trivalent OPV in 1963. Oral polio vaccine (OPV) is produced by weakening or attenuating polio viruses, until they are so weak that they lose the ability to cause disease. The trivalent oral vaccine (tOPV) protects against polioviruses 1, 2, and 3. tOPV has been used since the earliest efforts to eradicate polio and has helped reduce cases of the disease worldwide by more than 99%. Oral OPV vaccine is a safe and effective Vaccine Poliomyelitis to protect children from wild poliovirus paralysis. Over the past 10 years, more than 10 billion doses of OPV are in order and were administered to nearly 3 billion children worldwide. The vaccine is the appropriate means to achieve the goal of eradicating polio.
Price of Vaccine Poliomyelitis
The Vaccine Poliomyelitis is the wholesale price at 3.10 USD. But the wholesale prices for sale may vary highly as per the location of the pharmacy you visit.
Navigating our Pharmaceutical Marketplace
Being a global B2B pharmaceutical online marketplace, Pipelinepharma is structured to simplify pharmaceutical deals by providing you with an intuitive interface that is easy to engage with. The selection of Vaccine Poliomyelitis offerings can be narrowed down with the use of filters and easily weighed against one another according to medication prices and commercial terms. The advanced filters help you filter out the countries for these substance manufacturers and these substance suppliers that you are looking for. These also enable you to check the dossier status of this medicine, and the GMP approvals of the different variants of Vaccine Poliomyelitis. Also, each manufacturer or Vaccine Poliomyelitis supplier product description contains essential information about this substance including clinical data, stability zones, countries where Vaccine Poliomyelitis is already registered in. Manufacturers also have special, and delivery terms.
Establishing Commercial Ties
If you are a pharmaceutical licensing company or a distributor you can enter into deals or negotiations over these medicine offers with manufacturing companies after completing the free registration process and joining our online marketplace. This helps to ensure that you conclude the pharmaceutical deal at a reasonable cost and achieve the best cost/benefit ratio for your company while bypassing lengthy sourcing, negotiation, and ordering process. Once you have finalized a deal, you can look forward to a long-lasting business relationship with the manufacturers or Vaccine Poliomyelitis suppliers. This way, the marketplace allows you as a distributor to skip the process of shortlisting product manufacturers every time you are looking for in-licensing or distribution deals.
To keep up to the quality standards other than Good Manufacturing Practice approvals that this medicine manufacturers list has, we qualify their companies before they are on-boarded on the platform. This allows us to screen Vaccine Poliomyelitis manufacturers for the quality of the pharmaceutical products’ dossiers and protect against the risk of possible malpractices.